Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Toni A Campanella"'
Autor:
Jason C. Gallagher, Toni A Campanella
Publikováno v:
Infection and Drug Resistance. 13:4297-4308
Imipenem-relebactam (I-R) is a novel beta-lactam/beta-lactamase inhibitor combination given with cilastatin. It is indicated for the treatment of complicated urinary tract infections, complicated intra-abdominal infections, and hospital-acquired or v
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::727d68b00a1deb2eaca52e3ed64169bc
https://doi.org/10.2147/idr.s224228
https://doi.org/10.2147/idr.s224228
Autor:
Toni A, Campanella, Jason C, Gallagher
Publikováno v:
Infection and Drug Resistance
Imipenem-relebactam (I-R) is a novel beta-lactam/beta-lactamase inhibitor combination given with cilastatin. It is indicated for the treatment of complicated urinary tract infections, complicated intra-abdominal infections, and hospital-acquired or v
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a87b9ed66f27e883fc4f87b0e51435a6
https://pubmed.ncbi.nlm.nih.gov/33268997
https://pubmed.ncbi.nlm.nih.gov/33268997
Autor:
Amanda M. Roy, Thomas J Gintjee, Conan MacDougall, Jason C. Gallagher, Toni A Campanella, Monica A. Donnelley
Publikováno v:
Open Forum Infectious Diseases
Background Valganciclovir (VGC), an oral prodrug of ganciclovir (GCV), is 60% bioavailable. Manufacturer-recommended doses are adjusted for creatinine clearance (CrCl), but not weight (wt), while GCV doses are adjusted for CrCl and wt. Patients expos
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::251fa837afc78a9a3e63aea22a9db6e1
http://europepmc.org/articles/PMC7777869
http://europepmc.org/articles/PMC7777869